Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

StocksToTrade
timothysykes.com > news > etonpharmaceuticalsinc-eton-news-2026_08_16-2

Eton Pharmaceuticals Stock Soars After Massive Q2 Beat And Guidance Hike

4+ week, 18+ hour ago   (553+ words) On Tuesday, Eton Pharmaceuticals Inc. surged as breakthrough drug news fueled bullish sentiment; stocks have been trading up by 45.78 percent. Market Insights For Active Traders Q2 2026 non‑GAAP EPS of $0.43 crushed the $0.19 consensus, with revenue at $37.6M versus $27.12M and 99% year‑over‑year…...

StocksToTrade
timothysykes.com > news > etonpharmaceuticalsinc-eton-news-2026_08_15

Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike

4+ week, 1+ day ago   (452+ words) timothysykes.com Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike Eton Pharmaceuticals Inc. surged as stocks have been trading up by 45.78 percent following highly positive drug-approval news. What Traders Need To Know - Q2 2026 revenue hit $37.6M versus $27.12M consensus, driven by 99% year-over-year…...